 | Up a level |
Kandane-Rathnayake, Rangi and Louthrenoo, Worawit and Hoi, Alberta and Luo, Shue-Fen and Wu, Yeong-Jian J. and Chen, Yi-Hsing and Cho, Jiacai and Lateef, Aisha and Hamijoyo, Laniyati and Navarra, Sandra and Zamora, Leonid and Sockalingam, Sargunan and An, Yuan and Li, Zhanguo and Katsumata, Yasuhiro and Harigai, Masayoshi and Hao, Yanjie and Zhang, Zhuoli and Kikuchi, Jun and Takeuchi, Tsutomu and Basnayake, B. M. D. B. and Chan, Madelynn and Ng, Kristine Pek Ling and Tugnet, Nicola and Kumar, Sunil and Oon, Shereen and Goldblatt, Fiona and O'Neill, Sean and Gibson, Kathryn A. and Ohkubo, Naoaki and Tanaka, Yoshiya and Bae, Sang-Cheol and Lau, Chak Sing and Nikpour, Mandana and Golder, Vera and Morand, Eric F. and Collaboration, Asia-Pacific Lupus (2022) `Not at target': Prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study. Arthritis Research & Therapy, 24 (1). ISSN 1478-6354, DOI https://doi.org/10.1186/s13075-022-02756-3.
Apostolopoulos, Diane and Kandane-Rathnayake, Rangi and Louthrenoo, Worawit and Luo, Shue Fen and Wu, Yeong-Jian and Lateef, Aisha and Golder, Vera and Sockalingam, Sargunan and Navarra, Sandra and Zamora, Leonid and Hamijoyo, Laniyati and Katsumata, Yasuhiro and Harigai, Masayoshi and Chan, Madelynn and O'Neill, Sean and Goldblatt, Fiona and Lau, Chak Sing and Li, Zhan Guo and Hoi, Alberta and Nikpour, Mandy and Morand, Eric and Collaboration, Asia-Pacific Lupus (2020) Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: A multicentre cohort study. The Lancet Rheumatology, 2 (1). E24-E30. ISSN 26659913, DOI https://doi.org/10.1016/S2665-9913(19)30105-5.
